Background | CD30, a single chain glycoprotein, is synthesized as a 90kDa precursor which is processed in the Golgi complex into a membrane‐bound phosphorylated mature 105/120kDa glycoprotein. The CD30/Ki‐1 antigen is expressed by mononuclear Hodgkin and multinucleated Reed‐Sternberg cells in Hodgkin’s disease, by the tumor cells of a majority of anaplastic large cell lymphomas, and by a varying proportion of activated T and B cells. Ber‐H2 distinguishes large cell lymphomas derived from activated lymphoid cells from histiocytic malignancies and lymphomas derived from resting and precursor lymphoid cells or from anaplastic carcinomas. About one third of the Ki‐1 positive lymphomas lack the leukocyte common antigen (CD45). |
Tissue Specificity | Isoform 2: Detected in alveolar macrophages (at protein level). |
Post Translational Modifications | Phosphorylated on serine and tyrosine residues (Probable). Isoform 2 is constitutively phosphorylated. |
Function | Receptor for TNFSF8/CD30L. May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF-kappa-B. |
Database Links | Reactome: R-HSA-5669034 |
Cellular Localisation | Isoform 1: Cell MembraneSingle-Pass Type I Membrane ProteinIsoform 2: Cytoplasm |
Protein Name | Tumor Necrosis Factor Receptor Superfamily Member 8Cd30l ReceptorKi-1 AntigenLymphocyte Activation Antigen Cd30Cd Antigen Cd30 |
Alternative Names | Anti-Tumor Necrosis Factor Receptor Superfamily Member 8 antibodyAnti-Cd30l Receptor antibodyAnti-Ki-1 Antigen antibodyAnti-Lymphocyte Activation Antigen Cd30 antibodyAnti-Cd Antigen Cd30 antibodyAnti-TNFRSF8 antibodyAnti-CD30 antibodyAnti-D1S166E antibody |
Positive Control | Hodgkin lymphoma or anaplastic large cell lymphoma. |
Information sourced from Uniprot.org